Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SNIPERs—Hijacking IAP activity to induce protein degradation
Mikihiko Naito, Nobumichi Ohoka, Norihito Shibata
Drug Discovery Today Technologies (2019) Vol. 31, pp. 35-42
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik, Kayvon Pedram, Simon Wisnovsky, et al.
Nature (2020) Vol. 584, Iss. 7820, pp. 291-297
Open Access | Times Cited: 733
PROTACs: great opportunities for academia and industry
Xiuyun Sun, Hongying Gao, Yiqing Yang, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 513
Targeted protein degradation: mechanisms, strategies and application
Lin Zhao, Jia Zhao, Kunhong Zhong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 420
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
Green Ahn, Steven M. Banik, Caitlyn L. Miller, et al.
Nature Chemical Biology (2021) Vol. 17, Iss. 9, pp. 937-946
Open Access | Times Cited: 364
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Adam D. Cotton, Duy Nguyen, Josef A. Gramespacher, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 2, pp. 593-598
Open Access | Times Cited: 340
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha, Craig M. Crews
Cell chemical biology (2020) Vol. 27, Iss. 8, pp. 998-1014
Open Access | Times Cited: 335
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Tasuku Ishida, Alessio Ciulli
SLAS DISCOVERY (2020) Vol. 26, Iss. 4, pp. 484-502
Open Access | Times Cited: 255
Current strategies for the design of PROTAC linkers: a critical review
Robert I. Troup, Charlene Fallan, Matthias G. J. Baud
Exploration of Targeted Anti-tumor Therapy (2020) Vol. 1, Iss. 5
Open Access | Times Cited: 251
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
Michael J. Bond, Craig M. Crews
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 725-742
Open Access | Times Cited: 162
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
Laura M. Luh, U. Scheib, Katrin Juenemann, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 36, pp. 15448-15466
Open Access | Times Cited: 152
Ubiquitin ligases: guardians of mammalian development
David A. Cruz Walma, Zhuoyao Chen, Alex N. Bullock, et al.
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 5, pp. 350-367
Open Access | Times Cited: 119
E3 ligase ligand chemistries: from building blocks to protein degraders
Izidor Sosič, Aleša Bricelj, Christian Steinebach
Chemical Society Reviews (2022) Vol. 51, Iss. 9, pp. 3487-3534
Closed Access | Times Cited: 92
Targeted protein degrader development for cancer: advances, challenges, and opportunities
Yuan Fang, Shuhang Wang, Songzhe Han, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 5, pp. 303-317
Open Access | Times Cited: 47
Piperlongumine conjugates induce targeted protein degradation
Jing Pei, Yufeng Xiao, Xingui Liu, et al.
Cell chemical biology (2023) Vol. 30, Iss. 2, pp. 203-213.e17
Open Access | Times Cited: 43
Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders
Christian Steinebach, Yuen Lam Dora Ng, Izidor Sosič, et al.
Chemical Science (2020) Vol. 11, Iss. 13, pp. 3474-3486
Open Access | Times Cited: 106
An E3 ligase guide to the galaxy of small-molecule-induced protein degradation
Predrag Jevtić, Diane L. Haakonsen, Michael Rapé
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 1000-1013
Open Access | Times Cited: 100
Development of Small Molecule Chimeras That Recruit AhR E3 Ligase to Target Proteins
Nobumichi Ohoka, Genichiro Tsuji, Takuji Shoda, et al.
ACS Chemical Biology (2019) Vol. 14, Iss. 12, pp. 2822-2832
Closed Access | Times Cited: 92
Protein degradation technology: a strategic paradigm shift in drug discovery
Haobin Li, Jinyun Dong, Mao-Hua Cai, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 63
The rise of covalent proteolysis targeting chimeras
Ronen Gabizon, Nir London
Current Opinion in Chemical Biology (2021) Vol. 62, pp. 24-33
Closed Access | Times Cited: 61
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
Gabriel LaPlante, Wei Zhang
Cancers (2021) Vol. 13, Iss. 12, pp. 3079-3079
Open Access | Times Cited: 58
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
Green Ahn, Steven M. Banik, Carolyn R. Bertozzi
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 1072-1080
Open Access | Times Cited: 57
Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
Yingxu Fang, Jiaxing Wang, Min Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11454-11477
Closed Access | Times Cited: 49
Recent Advances in PROTAC-Based Antiviral Strategies
Haleema Ahmad, Bushra Zia, Hashir Husain, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 270-270
Open Access | Times Cited: 28
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
Dazhao Mi, Yuzhan Li, Haijun Gu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115444-115444
Closed Access | Times Cited: 27
E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology
Iacovos N. Michaelides, Gavin W. Collie
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3173-3194
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top